Source:http://linkedlifedata.com/resource/pubmed/id/18254722
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-8-11
|
pubmed:abstractText |
The present study was designed to investigate the relationship of isoforms of adiponectin to insulin sensitivity in subjects with HIV-associated insulin resistance in response to treatment with the thiazolidinedione, rosiglitazone. The two isoforms of adiponectin, HMW (high-molecular-mass) and LMW (low-molecular-mass), were separated by sucrose-gradient-density centrifugation. The amount of adiponectin in gradient fractions was determined by ELISA. Peripheral insulin sensitivity (Rd) was determined with hyperinsulinaemic-euglycaemic clamp, whereas hepatic sensitivity [HOMA (Homoeostasis Model Assessment) %S] was based on basal glucose and insulin values. Treatment with rosiglitazone for 3 months resulted in a significant improvement in the index of hepatic insulin sensitivity (86.4+/-15% compared with 139+/-23; P=0.007) as well as peripheral insulin sensitivity (4.04+/-0.23 compared with 6.17+/-0.66 mg of glucose/kg of lean body mass per min; P<0.001). Improvement in HOMA was associated with increased levels of HMW adiponectin (r=0.541, P=0.045), but not LMW adiponectin. The present study suggests that the HMW isoform of adiponectin is important in the regulation of rosiglitazone-mediated improvement in insulin sensitivity in individuals with HIV-associated insulin resistance, particularly in the liver.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adiponectin,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1470-8736
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
197-202
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18254722-Adiponectin,
pubmed-meshheading:18254722-Adult,
pubmed-meshheading:18254722-Blood Glucose,
pubmed-meshheading:18254722-CD4 Lymphocyte Count,
pubmed-meshheading:18254722-Female,
pubmed-meshheading:18254722-HIV Infections,
pubmed-meshheading:18254722-Humans,
pubmed-meshheading:18254722-Hypoglycemic Agents,
pubmed-meshheading:18254722-Insulin,
pubmed-meshheading:18254722-Insulin Resistance,
pubmed-meshheading:18254722-Liver,
pubmed-meshheading:18254722-Male,
pubmed-meshheading:18254722-Middle Aged,
pubmed-meshheading:18254722-Molecular Weight,
pubmed-meshheading:18254722-Protein Isoforms,
pubmed-meshheading:18254722-Thiazolidinediones,
pubmed-meshheading:18254722-Viral Load
|
pubmed:year |
2008
|
pubmed:articleTitle |
Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease.
|
pubmed:affiliation |
Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, N.I.H., Extramural
|